Trials / Completed
CompletedNCT03944694
White Cell Ratios as Markers of Delirium and Outcome in Acute Ischemic Stroke.
White Cell Ratios as Markers of Delirium and Outcome in Acute Ischemic Stroke. DELirium in Acute Ischemic Stroke [DELIAS]
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,001 (actual)
- Sponsor
- Pomeranian Medical University Szczecin · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to investigate the role of Neutrophil-to-Lymphocyte Ratio (NLR) and other derived white cell markers as early markers of delirium and outcome after acute ischemic stroke (AIS).
Detailed description
Delirium is an acute brain disorder, potentially reversible, commonly occurring in patients with acute ischemic stroke. The pathomechanism of delirium is related to neuroinflammatory process and oxidative stress. Search for readily available diagnostic marker that will aid clinicians in early identification of delirium is an on-going process. The aim of this study was to investigate the role of Neutrophil-to-Lymphocyte Ratio (NLR) and other derived white cell markers as early markers of delirium and outcome after acute ischemic stroke (AIS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Delirium assessment. | Full blood count analysis. |
Timeline
- Start date
- 2015-06-30
- Primary completion
- 2019-03-31
- Completion
- 2019-03-31
- First posted
- 2019-05-09
- Last updated
- 2019-05-10
Source: ClinicalTrials.gov record NCT03944694. Inclusion in this directory is not an endorsement.